Previous results demonstrated that chemotherapeutic drugs including melphalan, doxorubicin and bortezomib, increase DNAM1 ligand expression on MM cells14, 47 acting at transcriptional level through the activation of different signaling pathways. Here, CD226 is linked to Miyoshi myopathy.